Escitalopram for the Treatment of Self-Injurious Skin Picking

NCT00115011 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Impulse Control Disorders

Interventions

DRUG: Escitalopram

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]